An observational study in Abruptio Placentae; Affecting Fetus or Newborn, sponsored by Hatice Akkaya. Completed. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-29.
Sponsored by Hatice Akkaya · Observational
Placental abruption is a significant cause of both maternal morbidity and neonatal morbidity and mortality. Most abruptions accept to be related to a chronic placental disease process. Therefore, it is very important to understand these processes. To analyze maternal and neonatal effects of placental abruption(PA) through a novel classification in the presence of hypertension. Initial hemoglobin parameters were also compared to predict pregnancy outcomes in addition to hypertension.
Objective: We aimed to classify placental abruption according to hypertension status.
Methods: This retrospective cohort designed study was conducted on 115 pregnant women with placental abruption. The main parameters scanned and recorded from the hospital database and patient medical files. Two groups were classified regarding of presence or absence of hypertension (53 hypertensive, 62 normotensive). Maternal demographical and clinical characteristics (abdominal pain, vaginal bleeding) were recorded. APGAR scores below 5 at 1 and 5 min., fetal or neonatal death, admission and length of stay in Neonatal Intensive Care Unit(NICU) were also investigated and compared between the groups.
Two groups were formed according to presence or absence of hypertension (53 hypertensive, 62 normotensive) who has placental abruption.
Exclusion Criteria:
Two groups were classified regarding of presence or absence of hypertension (53 hypertensive, 62 normotensive).
Other: clinical assesment
Two groups were classified regarding of presence or absence of hypertension (53 hypertensive, 62 normotensive).
Other: clinical assesment
Comparison of Hypertensive group and normotensive group
blood pressure measurement
mm Hg
Time frame: 2 minute
hemogram parameters WBC(white blood cell) ,PLT(Platelet), MPV(mean platelet volume), HGB(hemoglobin), Neutrophil lymphocyte ratio..)
complete blood test retrospective complete blood count analysis
Time frame: first 1 hour
maternal and newborn length, weight
centimeters,kilogram
Time frame: 5 minute
APGAR score
1st and 5th minute newborn assesment
Time frame: 5 minute
No study locations are listed for this record.
Plan to share: No — The data belonging to participant only will be available to any researcher or editorial review board if needed.
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hatice Akkaya